Article Text
Abstract
Objectives Currently, no clear guidance defining the ideal candidate for minimally invasive interval debulking surgery (MI-IDS) exists. This study aimed to identify predictive factors of minimally invasive approach feasibility in advanced ovarian cancer (AOC) patients who were candidates to IDS after neoadjuvant chemotherapy (NACT).
Methods This was a single institution, retrospective study. Perioperative variables were used to predict the likelihood of MI-IDS using multivariable models. A nomogram was developed, and internal validation was performed using the bootstrapping correction technique.
Results Between 2014 and 2020, 108 (28.4%) and 272 (71.6%) patients underwent IDS by minimally invasive and open approach, respectively. Surgeon’s expertise (OR:6.27, 95% CI:3.25–12.08, p≤0.001), absence of omental cake (OR: 8.56, 95% CI: 4.22–17.33, p≤0.001), <2 peritoneal sites involvement (OR:3.11, 95% CI:1.45–6.65, p=0.003) and complete serological response (OR:2.23, 95% CI:1.21–4.11, p=0.010) appeared to be significantly correlated with MI-IDS feasibility at multivariate analysis.
A nomogram was built to visualize the effect of perioperative variables on the estimated probability of MI-IDS in patients with a clinical response after NACT. We used the four significant perioperative variables according to logistic regression. The calibration plot demonstrated good agreement between the predicted and actual probability of MI-IDS (p=0.93, Hosmer-Lemeshow test).
Conclusions A nomogram might represent a useful tool to choose the best surgical approach in patients with AOC undergoing IDS.